5 Results for "

YES1/SRC inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "YES1/SRC inhibitor" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-112096
CAS No.: 1914078-41-3
Purity:  99.17%
Synonyms: NXP900
Target:  

Src

Research Areas:  

Cancer

eCF506 (NXP900) is a highly potent and orally active YES1/SRC kinase inhibitor with an IC50 of 0.47 nM. eCF506 locks its target into its native “closed” conformation, thereby inhibiting both kinase activity and complex formation with protein partners. eCF506 can be used for the study of esophageal squamous cancer and breast cancer .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-135299
CAS No.: 2055918-71-1
Purity:  99.45%
Target:  

Src

Research Areas:  

Cancer

CH6953755 is a potent, orally active and selective YES1 kinase (a member of the SRC family) inhibitor with an IC50 of 1.8 nM. CH6953755 inhibits YES1 kinase, leading to antitumor activity against YES1 Gene -amplified cancers in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-136848
CAS No.: 2088179-99-9
Purity:  96.09%
SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines .
loading...
    loading...
Cat. No.: HY-112096S
Synonyms: NXP900-d5
eCF506-d5 (NXP900-d5) is deuterated labeled eCF506 (HY-112096). eCF506 is a highly potent and orally active YES1/SRC kinase inhibitor with an IC50 of 0.47 nM. eCF506 locks its target into its native “closed” conformation, thereby inhibiting both kinase activity and complex formation with protein partners. eCF506 can be used for the study of esophageal squamous cancer and breast cancer .
loading...
    loading...
Cat. No.: HY-208739
CAS No.: 2569011-03-4
Target:  

Src

Research Areas:  

Cancer

SRC tyrosine kinase IN-1 is a SRC inhibitor with an IC50 ranging from 1 μM to 10 μM. SRC tyrosine kinase IN-1 also acts as a YES1 inhibitor, with an IC50 of 1 μM to 10 μM. SRC tyrosine kinase IN-1 can be used in cancer research .
loading...
    loading...